Le Lézard
Classified in: Business
Subjects: ECO, RTG

National Bank of Canada completes share repurchase program


MONTREAL, Jan. 25, 2018 /CNW Telbec/ - National Bank of Canada (the "Bank") (TSX: NA) announces today the completion of its share repurchase program (the "Program"), as required by the conditions of the issuer bid exemption order issued to the Bank by the Ontario Securities Commission on January 10, 2018, in respect of the Program.

Under the Program agreement, on a continuous basis between January 16, 2018 and January 25, 2018, the Bank repurchased common shares of the Bank directly from a third party, subject to daily trading limitations and to an overall maximum of 1,500,000 common shares. The Program was included as part of the Bank's Normal Course Issuer Bid announced on May 31st, 2017.

The Bank purchased an aggregate of 1,500,000 common shares under the Program for an aggregate purchase price of $90,903,940.00. All common shares acquired under the Program were cancelled upon purchase by the Bank.

About National Bank of Canada
With $246 billion in assets as at October 31, 2017, 
National Bank of Canada, together with its subsidiaries, forms one of Canada's leading integrated financial groups.  It has more than 21,000 employees in knowledge-intensive positions and has been recognized numerous times as a top employer and for its commitment to diversity.  Its securities are listed on the Toronto Stock Exchange (TSX: NA).  Follow the Bank's activities at nbc.ca or via social media such as FacebookLinkedIn and Twitter.

 

SOURCE National Bank of Canada


These press releases may also interest you

at 06:35
Apogee Enterprises, Inc. will report its fiscal 2024 fourth quarter and full-year results on Thursday, April 18, 2024, before the market opens. The company will also host a conference call to discuss its financial results. This conference call will...

at 06:35
Metals Acquisition Limited ARBN 671 963 198 , a private limited company incorporated under the laws of Jersey, Channel Islands ("MAC" or the "Company") announces its Annual Report for the financial year ended 31 December 2023 ("2023 Annual Report")....

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Verde AgriTech Ltd ("Verde" or the "Company") announces its financial results for the full year ended December 31, 2023 ("FY 2023") and the fourth quarter 2023 ("Q4 2023"), as audited by Ernst & Young ("EY"). The FY 2023 audited results were...

at 06:30
Hut 8 Corp. ("Hut 8" or the "Company"), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America's largest Bitcoin miners, today announced its financial results for the six months ended...

at 06:30
Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively...



News published on and distributed by: